Zhijun Sun

Oncology · 2021

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Zhijun Sun trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Daniel S. Chen (in Oncology)

Papers from Zhijun Sun's perspective

Ordered by how strongly the researchers Zhijun Sun trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
  2. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  3. Hallmarks of cancer: the next generation. (Cell)
  4. Calreticulin exposure dictates the immunogenicity of cancer cell death (Nature Medicine)
  5. Safety and clinical activity of combined PD-1 (nivolumab) and CTLA-4 (ipilimumab) blockade in advanced melanoma patients (New England Journal of Medicine)
  6. Immunogenic cell death in cancer therapy. (Annual Review of Immunology)
  7. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. (Immunity)
  8. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. (New England Journal of Medicine)
  9. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy (Nature Medicine)
  10. PD-1 blockade induces responses by inhibiting adaptive immune resistance (Nature)

Their papers